Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1SOTATERCEPT1件: Sotatercept (Sotatercept)1件: Sotatercept (Sotatercept, sotatercept-csrk) 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬2件: 86, 284 💬
2Sotatercept - 45 mg/vial1件: Sotatercept (Sotatercept)1件: Sotatercept (Sotatercept, sotatercept-csrk) 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
3Sotatercept - 60 mg/vial1件: Sotatercept (Sotatercept)1件: Sotatercept (Sotatercept, sotatercept-csrk) 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
4Sotatercept - 60 mg/vialProduct Code: ACE-011 / MK-7962 Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962 Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 72.5-Product Name: Sotatercept - 45 mg/vialProduct Code: ACE-011 / MK-7962 Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962 Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 55-1件: Sotatercept (Sotatercept)1件: Sotatercept (Sotatercept, sotatercept-csrk) 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
5Sotatercept - 60 mg/vialProduct Code: ACE-011 / MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 72.5-Product Name: Sotatercept - 45 mg/vialProduct Code: ACE-011 / MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 55-1件: Sotatercept (Sotatercept)1件: Sotatercept (Sotatercept, sotatercept-csrk) 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
6Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg1件: Sotatercept (Sotatercept)1件: Sotatercept (Sotatercept, sotatercept-csrk) 💬 1件: ACVR2A 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 86 💬
7Sotatercept with prednisone boost2件: Prednisone,
Sotatercept (Sotatercept)		2件: Prednisone ,
Sotatercept (Sotatercept, sotatercept-csrk) 💬 		2件: ACVR2A,
NR3C1 💬 		5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 284 💬
8SotaterceptProduct Code: ACE-011 / MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Lyophilisate for solution for injectionRoute of administration of the placebo: Subcutaneous use----1件: 86 💬
9SotaterceptProduct Code: ACE-011/MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011/MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Lyophilisate for solution for injectionRoute of administration of the placebo: Subcutaneous use----1件: 86 💬